Antenatal magnesium sulphate reduces cerebral palsy after preterm birth, implementation into clinical practice needs to be accelerated globally to benefit preterm babies

source extracted confidence: high 2026-04-09
#humans #cerebral-palsy #magnesium-sulfate #pregnancy #infant-newborn

Antenatal magnesium sulphate reduces cerebral palsy after preterm birth, implementation into clinical practice needs to be accelerated globally to benefit preterm babies

Luyt et al., 2024 | Cochrane Database Syst Rev | Other

Citation

Luyt Karen. Antenatal magnesium sulphate reduces cerebral palsy after preterm birth, implementation into clinical practice needs to be accelerated globally to benefit preterm babies. Cochrane Database Syst Rev. 2024-Sep-24;9(9):ED000168. doi:10.1002/14651858.ED000168

Abstract

No abstract available

Key Findings

Requires manual extraction from full text

Outcomes Measured

  • Requires manual extraction

Population

Field Value
Population See abstract
Sample Size See abstract
Age Range See abstract
Condition See abstract

MeSH Terms

  • Humans
  • Cerebral Palsy
  • Magnesium Sulfate
  • Pregnancy
  • Infant, Newborn
  • Female
  • Infant, Premature
  • Premature Birth
  • Randomized Controlled Trials as Topic
  • Prenatal Care

Evidence Classification

  • Level: Other
  • Publication Types: Editorial
  • Vertical: magnesium

Provenance

Source extracted via PubMed E-utilities API on 2026-04-09